Time course of carcinoembryonic antigen after resection of lung cancer: A predictor of recurrence

Cancer Science

Volumn 94, Issue 8, 2003, Pages 741-744

  Yoshimasu, Tatsuya ^a   Kokawa, Yozo ^a   Oura, Shoji ^a   Hirai, Issei ^a   Sasaki, Rie ^a   Tanino, Hirokazu ^a   Sakurai, Teruhisa ^a   Okamura, Yoshitaka ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BIOSYNTHESIS; BLOOD LEVEL; CALCULATION; CANCER RECURRENCE; CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KINETICS; LUNG CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MINIMAL RESIDUAL DISEASE; NONLINEAR SYSTEM; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; REGRESSION ANALYSIS; TIME; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; KINETICS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; TIME FACTORS;

EID: 0141590371     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01512.x     Document Type: Article

References (16)

1. Semjonow A, Hamm M, Rathert P. Elimination kinetics of prostate-specific antigen serum and urine. Int J Biol Markers 1994; 9: 15-20.
2. Willemse PHB, Aalders JG, de Bruyn HWA, Mulder NH, Sleijfer DTh, de Vries EGE. CA-125 in ovarian cancer: relation between half-life, doubling time and survival. Eur J Cancer 1991; 27: 993-5.
3. Lange PH, Vogelzang NJ, Goldman A, Kennedy BJ, Fraley EE. Marker half-life analysis as a prognostic tool in testicular cancer. J Urol 1982; 128: 708-11.
4. Yedema CA, Kenemans P, Voorhorst F, Bon G, Schijf C, Beex L, Verstraeten A, Hilgers J, Vermorken J. CA 125 half-life in ovarian cancer: a multivariate survival analysis. Br J Cancer 1993; 67: 1361-7.
5. Ueda H, Kusano T, Iwasaki A, Inutsuka S. Postoperative change of serum carcinoembryonic antigen in bronchogenic carcinoma. Med Bull Fukuoka Univ 1991; 18: 187-91.
6. See WA, Cohen MB, Hoxie LD. Alpha-fetoprotein half-life as a predictor of residual testicular tumor. Cancer 1993; 71: 2048-54.
7. Pontes JE, Jabalameli P, Montie J, Foemmel R, Howard PD, Boyett J. Prognostic implications of disappearance rate of biologic markers following radical prostatectomy. Urology 1990; 36: 415-9.
8. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988; 139: 766-72.
9. van Straalen JP, Bossens MM, de Reijke TM, Sanders GT. Biological half-life of prostate-specific antigen after radical prostatectomy. Eur J Clin Chem Clin Biochem 1994; 32: 53-5.
10. Verhelst J, Vanden Broecke E, Van Meerbeeck J, De Backer W, Blockx P, Vermeire P. Calculation of half-life of carcinoembryonic antigen after lung tumour resection: a case report. Eur Respir J 1991; 4: 374-6.
11. Yoshimasu T, Miyoshi S, Maebeya S, Suzuma T, Bessho T, Hirai I, Tanino H, Arimoto J, Naito Y. Analysis of the early postoperative serum carcinoembryonic antigen time-course as a prognostic tool for bronchogenic carcinoma. Cancer 1997; 79: 1533-40.
12. Yoshimasu T, Maebeya S, Suzuma T, Bessho T, Tanino H, Arimoto J, Sakurai T, Naito Y. Disappearance curves for tumor markers after resection of intrathoracic malignancies. Int J Biol Markers 1999; 14: 99-105.
13. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki H, editors. Second International Symposium on Information Theory. Budapest: Akademiai Kaido; 1973. p. 267-81.
14. Thomas P, Zamcheck N, Rogers AE, Fox JG. Plasma clearance of carcinoembryonic antigen and asialo carcinoembryonic antigen by the liver of the nutritionally deficient rhesus monkey. Clin Lab Med 1982; 2: 459-67.
15. Primus FJ, Goldenberg DM, Hansen HJ. Metabolism of carcinoembryonic antigen in a human tumor-hamster host model. Fed Proc 1973; 32: 834.
16. Yamaguchi N, Kimoto K, Machino M, Takeuchi S, Uozumi G, Tanaka Y, Aoike A, Kawai K. Carcinoembryonic antigen in liver diseases. Elevated levels and liver diseases with alcohol abuse. Jpn J Gastroenterol 1980; 77: 37-42 (in Japanese).